Evommune, Inc. (EVMN)
25.71
-0.29
(-1.12%)
USD |
NYSE |
Mar 02, 16:00
26.07
+0.36
(+1.40%)
After-Hours: 20:00
Evommune Total Assets (Quarterly) : 84.54M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Moderna, Inc. | 12.34B |
| BillionToOne, Inc. | 327.52M |
| Nektar Therapeutics | 301.35M |
| CorMedix, Inc. | 750.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 267.68M |
| Shareholders Equity (Quarterly) | -183.14M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |